Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s12893-017-0291-1
Published Online: 2017-08-25
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Labori, Knut Jørgen
Lassen, Kristoffer
Hoem, Dag
Grønbech, Jon Erik
Søreide, Jon Arne
Mortensen, Kim
Smaaland, Rune
Sorbye, Halfdan
Verbeke, Caroline
Dueland, Svein